Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This prebiotic-based mouthwash was developed by ROSAIMPEX LTD in collaboration with the Medical University of Plovdiv specifically for the treatment of generalized gingivitis. The formulation is designed to promote a healthy oral microbiome by selectively supporting beneficial bacteria, thereby reducing plaque accumulation and gingival inflammation. In a randomized controlled clinical trial (NCT04733196) involving 180 patients, the prebiotic mouthwash demonstrated significant clinical efficacy in improving the gingival index, bleeding index, and oral hygiene index over a 21-day treatment period, performing comparably or superiorly to traditional antiseptic agents like chlorhexidine and hydrogen peroxide.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on prebiotic mouthwash (Plovdiv Medical University).